Security key
54948X109
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)
CUSIP: 54948X109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 141,152,375
- Total 13F shares
- 1,993,582
- Share change
- -77,622
- Total reported value
- $1,635,840
- Price per share
- $0.82
- Number of holders
- 31
- Value change
- -$60,859
- Number of buys
- 14
- Number of sells
- 13
Report period
Q2 2024
Institutions
31
Top holders
10
LUCD full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Lucid Diagnostics Inc. SEC filings
Lucid Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 54948X109
Recent filing periods:
Top shareholders of LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PAVmed Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
31,302,444
|
$43,926,720 | — | 15 Feb 2024 | |
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.51%
|
717,657
|
$581,230 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.4%
|
560,915
|
$454,285 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.11%
|
149,698
|
$132,281 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
155,757
|
$126,166 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
122,013
|
$98,818 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.04%
|
63,035
|
$51,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
51,646
|
$41,827 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.03%
|
42,379
|
$34,323 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
37,032
|
$29,992 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
34,671
|
$28,000 | — | 31 Mar 2024 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.02%
|
33,850
|
$27,419 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
29,301
|
$23,731 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
19,973
|
$16,178 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
18,428
|
$14,925 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
14,505
|
$11,747 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
13,145
|
$10,646 | — | 31 Mar 2024 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
3,831
|
$3,099 | — | 31 Mar 2024 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,761
|
$1,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
976
|
$790 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
315
|
$283 | — | 31 Mar 2024 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
157
|
$128 | — | 31 Mar 2024 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
50
|
$40 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
45
|
$35 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
34
|
$28 | — | 31 Mar 2024 | |
| M&R CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
25
|
$20 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3
|
$3 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2024 | |
| THOMPSON INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2024 | |
| Aster Angagaw |
3/4/5
|
Director |
—
class O/S missing
|
59,000
|
— | — | 18 Feb 2022 |
Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q2 2024
As of 30 Jun 2024,
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,993,582 shares.
The largest 10 holders included
LUMINUS MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, Lido Advisors, LLC, LPL Financial LLC, Verition Fund Management LLC, Geneos Wealth Management Inc., TWO SIGMA SECURITIES, LLC, and BlackRock Inc..
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
26
Q2 2024 holders
31
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.